Cannabinoids breakthrough signals hope for epilepsy treatment

Could cutting out mediators let cancer research off the leash?

Novartis has launched a programme to add novel treatments to its malaria pipeline

We find out what it takes for pharma air freight hubs to get certified

Is the FDA's decision to spotlight companies blocking generic competition justified?

Life sciences firms need to adapt how they approach data management

The industry is undergoing dramatic change as new tech brings disruption